Clinicopathological Significance Of Sox4, Beta-Catenin, And Tcf4 Expression In Esophageal Squamous Cell Carcinoma
Yanzi Qin,Wenjun Zhao,Damin Chai,Yurong Ou,Shiwu Wu,Qiong Wu,Jin Gao,Zhaonan Bian,Yisheng Tao,Li Ma
2019-01-01
Abstract:Background: Highly expressed SRY-related high mobility group box 4 (SOX4), according to previous reports, forecasts poor prognosis in patients with cancer. WNT/beta-catenin pathways are often involved in oncogenesis and cancer development. The current study investigated association levels between SOX4, beta-catenin, or T-cell factor 4 (TCF4) and clinical-pathological characteristics of patients with esophageal squamous cell carcinoma (ESCC), examining the roles of these proteins in invasion and metastasis of ESCC. Methods: Proteins of SOX4, beta-catenin, and TCF4 were examined by immunohistochemistry (IHC), employing 220 paraffin-embedded ESCC tissue specimens and 60 normal esophageal squamous epithelium tissue samples. Results: Expression levels of SOX4, beta-catenin, and TCF4 were upregulated in ESCC patients, compared with controls. High expression levels of SOX4, beta-catenin, or TCF4 in ESCC were positively correlated with age, tumor diameter, lymph node metastasis (LNM), depth of invasion, TNM stage, and distant metastasis. Univariate analysis demonstrated that overexpression of SOX4, beta-catenin, or TCF4 was positively associated with shorter overall survival (OS)times. Multivariate analysis indicated that independent predictors of prognosis in patients with ESCC included age, distant metastasis, and overexpression of SOX4, beta-catenin, and TCF4. Conclusion: Results suggest that SOX4, beta-catenin, and TCF4 may play key roles in invasion and metastasis in patients with ESCC. Moreover, SOX4, beta-catenin, and TCF4 should be considered potential prognostic markers of ESCC.